Oncocyte Corporation Announces $10.2 Million Private Placement of Securities
Oct 02, 2024•10 months ago
Contract Type
partnership
Description
Oncocyte Corporation has entered into a securities purchase agreement with new and existing investors, including Bio-Rad Laboratories, Inc. The company expects to receive approximately $10.2 million from the private placement, which will be used for working capital and general corporate purposes. This partnership demonstrates strong support from both current and new shareholders, including their corporate partner, Bio-Rad Laboratories, Inc.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months